Mass Torts

October 1, 2026

Call of Duty Video Game Addiction Lawsuit

On this page, our national mass tort lawyers look at Call of Duty video game addiction lawsuits. We look at the features of Call of Duty that plaintiffs allege are intended to make the game highly addictive, Activision’s alleged failure to warn about the addictive nature of the game, the harmful effects of video game addiction, and the potential settlement value of these cases.

The battlefield of these cases is whether Activision and the developers of Call of Duty designed and marketed a product that can cause foreseeable harm to minors and young adults, and whether they failed to warn families about that risk.

We believe it did. Our lawyers contend that Call of Duty addiction lawsuits are product liability cases involving a defective product. We allege the game was engineered with reward loops, progression systems, microtransactions, battle passes, social pressure, and endless online competition that can push vulnerable users into compulsive play.

September 30, 2026

Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are reviewing hair relaxer cancer lawsuits for women across the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation now includes nearly 12,000 plaintiffs. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. No hair relaxer settlement has been announced, and no plaintiff has received a settlement payout through the federal MDL. The latest hair relaxer lawsuit update is that Judge Mary Rowland has lifted a discovery stay for a group of defendants after concluding that settlement discussions had not produced enough progress to justify keeping those cases frozen.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

September 28, 2026

Suboxone Tooth Decay Lawsuit Update

by Ronald V. Miller, Jr.

This page explains the Suboxone tooth decay lawsuits, the dental injuries linked to Suboxone film, and where the federal MDL stands in 2026.

The core claim in the Suboxone litigation is straightforward: plaintiffs allege that Indivior and related defendants knew, or should have known, that Suboxone film could cause severe dental damage, including tooth decay, enamel erosion, broken teeth, tooth loss, and expensive dental reconstruction. Plaintiffs contend the companies failed to warn patients and prescribing doctors until the FDA forced a dental warning in 2022.

Contact Us About a Suboxone Tooth Decay Lawsuit

September 28, 2026

Benzene Lawsuits and Acute Myeloid Leukemia

by Ronald V. Miller, Jr.

You may be here because you or someone in your family has been diagnosed with acute myeloid leukemia (AML) or another blood cancer after years of benzene exposure. Benzene lawsuits most often focus on AML and related blood cancers linked to workplace or product exposure. These conditions are devastating on their own. When they are tied to a toxic chemical like benzene, the frustration is even greater.

Benzene has been tied to cancer for decades. The research is clear. Workers have brought benzene exposure lawsuits across the country, and juries have awarded significant verdicts in many cases. Families have negotiated benzene lawsuit settlements after showing that their exposure on the job or in the community caused leukemia, multiple myeloma, or other blood-related diseases.

If you are considering a benzene lawsuit, you are likely wondering how the process works, whether your case qualifies, and what kind of compensation is possible. The answers are specific to your situation, but the starting point is always the same: understanding how exposure happens and how the law allows victims to bring claims.

September 25, 2026

Gabapentin Dementia Lawsuit

by Ronald V. Miller, Jr.

Gabapentin lawsuits are now being investigated because new research has raised concerns that long-term or repeated gabapentin use is linked to dementia, mild cognitive impairment, memory loss, confusion, and other cognitive problems.

These cases are still developing, and we are in the early rounds of this. There is no nationwide gabapentin dementia class action lawsuit or MDL and there have not been any settlements. In fact, we are unaware of a single lawsuit filed in the U.S. alleging Gabapentin causes these injuries. But the science is advancing quickly, and the deeper our lawyers dig into these cases, the more we believe in them.

If you are reading this and are not a patient on Gabapentin, let’s talk briefly about what it is. Gabapentin is one of the most commonly prescribed medications in the United States. It is sold under the brand name Neurontin and is also available as a generic. Doctors prescribe Neurontin for seizures, shingles-related nerve pain, and a long list of off-label conditions, including back pain, neuropathy, anxiety, migraines, fibromyalgia, sleep problems, and other chronic pain complaints.

September 25, 2026

Olympus Scope Lawsuit

by Ronald V. Miller, Jr.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died from these medical scopes.

What happened? These awful infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat.

So you had patients who went to the hospital, often getting diagnostic or therapeutic procedures that they did not think would be a big deal, only to come out with infections that damaged organs, required months of intensive care, or, tragically, proved fatal.

September 24, 2026

Gambling Addiction Lawsuits

by Ronald V. Miller, Jr.

Our lawyers are primarily investigating gambling addiction lawsuits involving DraftKings and FanDuel.

These lawsuits revolve around the idea that these companies had the data to identify compulsive gambling behavior. Did they use that data to protect gambling addicts or did they use this information to target them?

No, just the opposite. Instead of slowing vulnerable users down, DraftKings, FanDuel, and other defendants allegedly saw them as cash cow targets and pushed bonus bets, deposit matches, and anything else they could to keep them addicted and burning money on their betting apps. So the issue at trial is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.

September 22, 2026

Vaginal Mesh Lawsuit

by Ronald V. Miller, Jr.

Women are still filing vaginal mesh lawsuits and bladder sling lawsuits in 2026, but this is no longer the enormous federal mass tort it was a decade ago. The old federal MDLs have closed. Most legacy claims have been resolved, and the remaining litigation is concentrated in individual cases and state-court dockets, including active Johnson & Johnson and Ethicon pelvic mesh cases in New Jersey.

A viable case now depends less on the history of the prior litigation and more on specific evidence: the manufacturer and product, the date of implantation, mesh erosion or another documented complication, revision surgery, and medical evidence linking the implant to the injury. Our lawyers are currently focused on selected claims involving products from Johnson & Johnson/Ethicon and Coloplast. We are not accepting new Boston Scientific mesh claims.

Substantively updated: October 1, 2026

September 21, 2026

Bard PowerPort Lawsuit

by Ronald V. Miller, Jr.

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The most recent trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

September 18, 2026

NEC Baby Formula Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. At their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families or give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to file an NEC baby formula lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.